Related Experiment Video

Updated: Aug 25, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

Technology evaluation: Canvaxin, John Wayne Cancer Institute/CancerVax

Susannah E Motl1

  • 1University of Tennessee Health Science Center, 875 Monroe Ave, Suite 112, Memphis, TN 38163, USA. smotl@utmem.edu

Current Opinion in Molecular Therapeutics
|March 12, 2004
PubMed

Insights

CancerVax is developing Canvaxin, a novel cancer vaccine targeting over 20 tumor antigens. This biotechnology approach is currently in Phase III trials for melanoma and Phase II for colon cancer treatment.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Melanoma and colon cancer represent significant global health challenges.
  • Current treatment paradigms for these cancers have limitations.
  • Novel therapeutic strategies are needed to improve patient outcomes.

Purpose of the Study:

  • To evaluate the safety and efficacy of Canvaxin, a multi-antigen cancer vaccine.
  • To investigate the potential of Canvaxin as a treatment for melanoma.
  • To assess Canvaxin's utility in managing colon cancer.

Main Methods:

  • Canvaxin, a vaccine comprising over 20 tumor antigens, is under co-development by CancerVax and the John Wayne Cancer Institute.
  • The vaccine is currently being investigated in clinical trials.
  • Phase III clinical trials are ongoing for melanoma.
  • Phase II clinical trials are underway for colon cancer.

Main Results:

  • Clinical trial data regarding the efficacy and safety of Canvaxin are being collected.
  • Preliminary findings are anticipated from ongoing Phase II and III trials.

Conclusions:

  • Canvaxin represents a promising biotechnology-driven therapeutic candidate for melanoma and colon cancer.
  • Further clinical evaluation is essential to establish Canvaxin's role in cancer treatment.
  • The multi-antigen approach may offer a broad-spectrum immune response against cancer cells.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...